Antibiotic resistance in *P. aeruginosa*: How corporate-driven drug development and hospital hygiene failures amplify a structural crisis
Original framing: “Superbug P. aeruginosa uses two protein plugs to seal channels against antibiotics” — Phys.org
The rise of *P. aeruginosa* resistance mirrors the **1940s–50s penicillin crisis**, when unchecked antibiotic use in hospitals and agriculture led to *Staphylococcus aureus* becoming methicillin-resistant (MRSA). The **1969 Swann Report** in the UK and the **1976 U.S. Public Health Service Act** both warned of antibiotic overuse, yet corporate lobbying (e.g., **Pfizer’s 1980s–90s agricultural antibiotic campaigns**) delayed regulations. Today, the **2007 FDA Delamanidid Act** and the **2017 WHO Global Action Plan** repeat these failures by treating resistance as a technical problem rather than a **policy-induced catastrophe**. The **1998 *E. coli* O157:H7 outbreak** in Walkerton, Canada—linked to privatized water systems—also foreshadowed how **neoliberal healthcare austerity** enables superbug spread.
The path forward requires **Three Pillars**: (1) **Restorative Justice**—reparations for stolen antimicrobial knowledge and **binding corporate accountability**; (2) **One Health Ecology**—linking hospitals, farms, and water systems via **community-led surveillance**; and (3) **Trickster Disruption**—using **art, humor, and guerilla science** to expose the absurdity of a system that lets **10 million die by 2050** while prioritizing patents over lives.
The *P. aeruginosa* crisis is not a biological inevitability but a **policy-induced tragedy**—one that can only be undone by **rewriting the rules of power, not just the rules of biology**.